JOURNAL OF CLINICAL SURGERY ›› 2021, Vol. 29 ›› Issue (11): 1044-1046.doi: 10.3969/j.issn.1005-6483.2021.11.014

Previous Articles     Next Articles

A retrospective study of segmentectomy and wedge resection in the treatment of peripheral lung cancer with a diameter of ≤2cm

  

  1. Department of Thoracic Surgery,Zhongnan Hospital of Wuhan University,Wuhan,430071,China
  • Online:2021-11-20 Published:2021-11-20

Abstract: Objective To compare the therapeutic effects of segmentectomy and lung wedge resection for lung cancer with a diameter ≤ 2cm and CT shows that ground glass nodules ≥ 50%.
Methods From January 2020 to July 2021,38 patients with lung adenocarcinoma who underwent segmental resection or pulmonary wedge resection at Zhongnan Hospital of Wuhan University were enrolled.Among them:16 cases in the segmental resection group(segmental resection group);22 cases in the wedge resection group(wedge resection group),compared the clinical data of the two groups of patients.
Results There was no perioperative death in both groups.Operation time [(131.6±40.2)min vs.(20.3±10.2) min],intraoperative blood loss [(67.2±49.1) ml vs.(9.9±5.1) ml],drainage tube extubation time[(3.5±1.5)d vs.(1.5±0.5)d] and hospitalization time [(4.5±3.5)d vs.(2.5±1.5)d] in the segmental resection group and the wedge resection group were statistically significant(P<0.05).All these aspects,resection the wedge resection group was significantly better than the segment resection group.
Conclusion Pulmonary wedge resection is beneficial to the rapid recovery of patients with peripheral(1/3 of outside the lung parenchyma) and pulmonary adenocarcinoma with diameter ≤2cm.

Key words: lung cancer, segmentectomy, wedge resection

[1] LIU Xiaojun, HAN Xiao, WANG Pan, et al.. Application of three-dimensional imaging technology in thoracoscopic lung surgery [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(9): 830-833.
[2] . Efficacy and safety of Flexthreedimensional thoracoscopic lobectomy and lymph node dissection in the treatment of primary lung cancer [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(8): 717-720.
[3] . Application analysis of threedimensional reconstruction technology of chest CT plain scan and threedimensional reconstruction technology of enhanced scan in anatomical segmentectomy [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(8): 730-734.
[4] ZHENG Yanhong, LIANG Zhu, MA Bingtai, et al.. Relationship between lymph node metastasis and clinical pathology in patients with left lung cancer resection combined with regional lymph node dissection [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(5): 463-465.
[5] WAN Zhihua, WU Ruifeng, LIU Weiming, et al.. Efficacy of 3D thoracoscopic lobectomy in the treatment of primary lung cancer [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(3): 269-272.
[6] . Effect of total thoracoscopic surgery on tumor markers NSE,PCT,immune markers CD3+,CD4+ and CD8+ in lung cancer patients and its correlation with prognosis [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(2): 140-142.
[7] SUN Linao, LI Changsheng, ZHOU Xuefeng.. Expression and clinical significance of Glycine N-methyltransferase in lung cancer and adjacent tissues [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(10): 945-948.
[8] BAIDURULA·Ainitu, KAISAER·Wufuer, FU Yi, et al.. Effect of lobectomy and sublobar lobectomy on pulmonary function and recurrence in elderly patients with early NSCLC [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(10): 949-952.
[9] ZHOU Chao, LI Wentao, WANG Rui, et al. Clinical analysis of 13 cases of synchronous multiple primary lung cancer treated by the combination of thoracoscopy and bronchoscopy [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(1): 38-41.
[10] LI Zengliang, PAN Yanqing, MA Guodong.. Predictive value of CTR in patients with multiple ground-glass opacity (GGO) nodules [J]. JOURNAL OF CLINICAL SURGERY, 2020, 28(9): 841-844.
[11] CHEN Gang, WANG Fangqing, RUAN Weimin, et al.. Application study of individualized three-dimensional reconstruction of pulmonary nodules in thoracoscopic segmentectomy [J]. JOURNAL OF CLINICAL SURGERY, 2020, 28(7): 643-646.
[12] WANG Xunhao, SHEN Lei, DAI Xiyong.. Clinical analysis of 52 patients with lung cancer complicated with pulmonary tuberculosis [J]. JOURNAL OF CLINICAL SURGERY, 2020, 28(7): 647-649.
[13] DENG Yu, HAO Bo, GENG Qing.. Current status and prospect of treatment for small cell lung cancer [J]. JOURNAL OF CLINICAL SURGERY, 2020, 28(7): 696-699.
[14] . The correlation study of preoperative platelet to lymphocyte ratio,neutrophil to lymphocyte ratio and lymphocyte to monocyte ratio on the prognosis of patients with nonsmall cell lung cancer [J]. JOURNAL OF CLINICAL SURGERY, 2020, 28(11): 1020-1024.
[15] TENG Jiping, YANG Zhiyin, HU Xiaohua.. The efficacy of gefitinib versus pemetrexed combined with nedaplatin in patients with stage ⅢA-N2 EGFR mutation-positive lung adenocarcinoma [J]. JOURNAL OF CLINICAL SURGERY, 2020, 28(10): 938-942.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] . [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(9): 846 -847 .
[2] . [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(9): 897 -899 .
[3] . [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(10): 924 -925 .
[4] MAO Jinqian, LI Yiqing, HU Jin, et al.. Analysis of prognostic factors of primary hepatic angiosarcoma based on SEER database[J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(10): 980 -984 .
[5] . [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(10): 999 -1000 .
[6] . [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(10): 1001 .
[7] . [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(11): 1001 .
[8] LIN Ximeng, CHEN Minshan. Clinical features and diagnostic criteria of hepatobiliary duct cell carcinoma[J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(11): 1004 -1007 .
[9] HUANG Cheng, SUN Huichuan. The road to radical cure in advanced hepatocellular carcinoma——conversion therapy[J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(11): 1008 -1011 .
[10] WANG Guanyu. Conversion therapy for hepatocellular carcinoma: strategies and current status[J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(11): 1012 -1014 .